cyan AG
- WKN: A2E4SV
- ISIN: DE000A2E4SV8
- Land: Deutschland
Nachricht vom 14.01.2021 | 11:57
cyan AG: Convertible bond program with a total volume of up to EUR 8.4 million approved
cyan AG / Key word(s): Financing cyan AG: Convertible bond program with a total volume of up to EUR 8.4 million approved Munich, January 14, 2021 - The Management Board of cyan AG today resolved, with the consent of the Supervisory Board, a Convertible Notes Funding Program ("CNFP") authorizing the issuance of convertible notes with a total volume of up to EUR 8.4 million. The program comprises up to eight consecutive tranches, each with a total nominal amount of EUR 1.05 million. Each tranche will consist of 105 convertible bonds with a nominal value of EUR 10,000 per convertible bond. The term of each tranche will be 24 months after issuance. The issue will take place under exclusion of subscription rights of existing shareholders. After issuing a tranche, cyan AG has the right, but not the obligation, to draw further tranches out of the seven outstanding tranches. The issuance of the first tranche is mandatory. The interest rate is 0.0%. The conversion price is set at 95% of the lowest daily volume-weighted average price of the last six trading days (XETRA) prior to exercise of the conversion right. However, it amounts to at least EUR 10.47 and thus at least 80% of the value of the average closing price (XETRA) of the share on the ten trading days prior to the issue of the bond. cyan AG has simultaneously entered into an agreement with NICE & GREEN S.A., Switzerland, under which NICE & GREEN S.A. is obliged to subscribe to the respective tranches issued by cyan AG. The transaction was accompanied by ODDO SEYDLER BANK AG as Capital Markets Advisor. Information and Explanation of the Issuer to this News: About cyan Today, the group of companies has more than 50 international customers, through which cyan prod-ucts are sold to approximately 50 million end customers. cyan can offer products along the entire value chain from platform, data optimization to cyber security. In addition, cyan operates its own Research & Development Centre with the aim of identifying trends in the industry at an early stage and developing optimal product solutions. In December 2018, cyan was able to win a global group contract with Orange in an international tendering process. cyan's cooperation partners include the world's leading insurance broker Aon or Magenta Telekom. Further information is available at www.cyansecurity.com. Investor Contact: Press Contact:
14-Jan-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | cyan AG |
Theatinerstraße 11 | |
80333 Munich | |
Germany | |
Internet: | www.cyansecurity.com |
ISIN: | DE000A2E4SV8 |
WKN: | A2E4SV |
Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Scale), Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1160624 |
End of Announcement | DGAP News Service |
Interaktiv
Weitere News
GBC-Fokusbox

Northern Data: "Waren zum richtigen Zeitpunkt mit dem richtigen Konzept am Markt"
Kryptowährungen, allen voran Bitcoin, sind zuletzt mit deutlichen Steigerungen wieder in den Investorenfokus gerückt. Northern Data, ein Spezialist für High Performance Computing, zählt laut eigenen Angaben zu den weltweit führenden Anbietern für Infrastruktur im Bereich Bitcoin-Mining. Wir haben mit dem Gründer und CEO Aroosh Thillainathan über die Perspektiven für Bitcoin und die Wachstumsaussichten für die Northern Data gesprochen.
Der AKTIONÄR News

20. Januar 21:39 Schlussglocke: Wall Street feiert Biden – Netflix, Apple, Alphabet, ...
20. Januar 21:00 Wasserstoff-Wahnsinn – Revolution oder Hype? Nel, Plug Power, ITM ...
20. Januar 20:32 Netflix-Aktie explodiert – stärkster Sprung seit 4 Jahren – und nun?
20. Januar 18:52 Nach Xpeng und Nio: BYD besorgt sich frisches Geld – Aktie unter ...
20. Januar 17:29 DAX trotz Ifo-Warnung nahe 14.000 – Rekorde für MDAX und SDAX – ...
News im Fokus

Merck KGaA: Merck KGaA bricht klinische Studie für bintrafusp alfa (INTR@PID Lung 037) ab
20. Januar 2021, 13:30
Aktuelle Research-Studie
Original-Research: GBC Insider Focus Index (von GBC AG): GBC Insider Focus Index
20. Januar 2021